Enable JavaScript to visit this website.

What is XELJANZ?

XELJANZ (tofacitinib) is a prescription medicine called a Janus kinase (JAK) inhibitor used to treat:

  • Adults with moderately to severely active ulcerative colitis when medicines called tumor necrosis factor (TNF) blockers did not work well or cannot be tolerated

It is not known if XELJANZ is safe and effective in children or in people with Hepatitis B or C.

XELJANZ is not recommended for people with severe liver problems.

Questions: 
What do I do if my insurance coverage changes?
Body: 

Health plans can change—so can your health insurance and prescription benefits. Once your new plan begins, XELSOURCE may help by contacting your insurance company on your behalf to understand your insurance benefits for XELJANZ, including what your out-of-pocket costs will be.

weight: 
3